ArriVent BioPharma
AVBP
AVBP
99 hedge funds and large institutions have $732M invested in ArriVent BioPharma in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
12.82% more ownership
Funds ownership: 85.46% → 98.29% (+13%)
17% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 30
Holders
99
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$29.4M | |
| 2 | +$23.4M | |
| 3 | +$15.2M | |
| 4 |
F1I
Fund 1 Investments
Rincon,
Puerto Rico
|
+$11.5M |
| 5 |
CLG
Cooperman Leon G
|
+$9.17M |
Top Sellers
| 1 | -$6.56M | |
| 2 | -$2.52M | |
| 3 | -$2.47M | |
| 4 |
Two Sigma Investments
New York
|
-$765K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$674K |
